(Q45395629)

14 December 2017

title

Hair repigmentation associated with the use of lenalidomide: graying may not be an irreversible process! (English)

1 reference

14 December 2017

Constantin A Dasanu

1

1 reference

14 December 2017

Demytra Mitsis

series ordinal

2

1 reference

14 December 2017

Doru T Alexandrescu

series ordinal

3

1 reference

14 December 2017

publication date

22 March 2012

1 reference

Journal of Oncology Pharmacy Practice

14 December 2017

published in

1 reference

14 December 2017

volume

19

1 reference

14 December 2017

issue

2

1 reference

14 December 2017

page(s)

165-169

1 reference

Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1078155212442561

Dermatologic side effects of thalidomide in patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212442561

Dermatologic adverse effects of lenalidomide therapy for amyloidosis and multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212442561

Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212442561

Mechanisms of cutaneous toxicities to EGFR inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212442561

Epidermal growth factor as a biologic switch in hair growth cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212442561

Acquired trichomegaly with topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212442561

Erlotinib-induced trichomegaly in a male patient with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212442561

Cetuximab-associated elongation of the eyelashes: case report and review of eyelash trichomegaly secondary to epidermal growth factor receptor inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212442561

Trichomegaly following treatment with gefitinib (ZD1839).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212442561

The biology of hair follicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212442561

Melanogenesis is coupled to murine anagen: toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212442561

Mode of redifferentiation and melanogenesis of melanocytes in mouse hair follicles. An ultrastructural and cytochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212442561

Biochemical control of melanogenesis and melanosomal organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212442561

Towards defining receptors for L-tyrosine and L-dopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212442561

Melanin pigmentation in mammalian skin and its hormonal regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212442561

Pharmacological properties of thalidomide and its analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212442561

Repigmentation of gray hair after thyroid hormone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212442561

Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212442561

21 January 2018

Identifiers

DOI

10.1177/1078155212442561

1 reference

14 December 2017

1 reference